• G00117

• 2.4.3.8
• 2.4.99.-
• 3.2.1.18

RES
1b:b-dglc-HEX-1:5
2b:b-dgal-HEX-1:5
3b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
4s:n-acetyl
5b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
6s:n-acetyl
7b:b-dgal-HEX-1:5
8s:n-acetyl
9b:b-dgal-HEX-1:5
10b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
11s:n-acetyl
12b:a-dgro-dgal-NON-2:6|1:a|2:keto|3:d
13s:n-acetyl
LIN
1:1o(4+1)2d
2:2o(3+2)3d
3:3d(5+1)4n
4:3o(8+2)5d
5:5d(5+1)6n
6:2o(4+1)7d
7:7d(2+1)8n
8:7o(3+1)9d
9:9o(3+2)10d
10:10d(5+1)11n
11:10o(8+2)12d
12:12d(5+1)13n

• Jacobs BC et al. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol. 1995 Feb;37:(2):260-4. doi: 10.1002/ana.410370218. PMID: 7531419.

• Yuki N et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol. 1994 Nov;36:(5):791-3. doi: 10.1002/ana.410360517. PMID: 7526777.

• Boffey J et al. Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes. J Neuroimmunol. 2004 Jul;152:(1-2):98-111. doi: 10.1016/j.jneuroim.2004.04.002. PMID: 15223242.

• Kotani M et al. An immunohistochemical technique with a series of monoclonal antibodies to gangliosides: their differential distribution in the rat cerebellum. Brain Res Brain Res Protoc. 1997 May;1:(2):152-6. doi: 10.1016/s1385-299x(96)00025-6. PMID: 9385079.

• Ozawa H et al. Generation of one set of monoclonal antibodies specific for b-pathway ganglio-series gangliosides. Biochim Biophys Acta. 1992 Jan 24;1123:(2):184-90. doi: 10.1016/0005-2760(92)90110-h. PMID: 1371229.

• Kotani M et al. Developmental changes of ganglioside expressions in postnatal rat cerebellar cortex. Brain Res. 1995 Nov 27;700:(1-2):40-58. doi: 10.1016/0006-8993(95)00923-e. PMID: 8624728.

• Townson K et al. Sulfatide binding properties of murine and human antiganglioside antibodies. Glycobiology. 2007 Nov;17:(11):1156-66. doi: 10.1093/glycob/cwm095. PMID: 17855742.

• Goodyear CS et al. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest. 1999 Sep;104:(6):697-708. doi: 10.1172/JCI6837. PMID: 10491405.

• Kotani M et al. Differential distribution of major gangliosides in rat central nervous system detected by specific monoclonal antibodies. Glycobiology. 1993 Apr;3:(2):137-46. doi: 10.1093/glycob/3.2.137. PMID: 8490240.

• Boffey J et al. Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire. J Neuroimmunol. 2005 Aug;165:(1-2):92-103. doi: 10.1016/j.jneuroim.2005.04.011. PMID: 15967512.

• Kawashima I et al. Immunocytochemical analysis of gangliosides in rat primary cerebellar cultures using specific monoclonal antibodies. Brain Res. 1996 Sep 2;732:(1-2):75-86. doi: 10.1016/0006-8993(96)00493-3. PMID: 8891271.

• Willison HJ et al. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. Brain. 2004 Mar;127:(Pt 3):680-91. doi: 10.1093/brain/awh083. PMID: 14960498.

• Tai T et al. Different fine binding specificities of monoclonal antibodies to disialosylganglioside GD2. J Biochem. 1988 Apr;103:(4):682-7. doi: 10.1093/oxfordjournals.jbchem.a122329. PMID: 3170507.